By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves Roche (Genentech) Skin Cancer Drug–Zelboraf
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > FDA Approves Roche (Genentech) Skin Cancer Drug–Zelboraf
Business

FDA Approves Roche (Genentech) Skin Cancer Drug–Zelboraf

BarbaraDuck
BarbaraDuck
Share
3 Min Read
SHARE

Cancer drugs certainly are not cheap and for a year, this one is right up there with Provenge in cost with over 100k if it was prescribed for a year.  The diagnosis part of $150 is the easy financial part of this.  In the clinical trials though it was noted that some patients become resistant to the drug.  The approval came earlier than anticipated from the FDA based on the strong clinical data.  BD 

Cancer drugs certainly are not cheap and for a year, this one is right up there with Provenge in cost with over 100k if it was prescribed for a year.  The diagnosis part of $150 is the easy financial part of this.  In the clinical trials though it was noted that some patients become resistant to the drug.  The approval came earlier than anticipated from the FDA based on the strong clinical data.  BD 

U.S. drug regulators approved a targeted skin cancer drug from Roche Holding, offering new hope for patients with the deadliest form of imagecancer after years of few options.

The U.S. Food and Drug Administration was two months ahead of schedule in approving the drug, under the brand name Zelboraf, along with a companion diagnostic test that identifies which patients have a specific genetic mutation that means they will benefit from the treatment.

Zelboraf was developed in partnership with Daiichi Sankyo and is the second drug to be approved for melanoma this year, after Yervoy from Bristol-Myers Squibb

Roche said Zelboraf would cost about $56,400 for a six-month course of treatment in the United States. Bristol’s Yervoy costs $120,000 for a course of treatment. The diagnostic test will cost around $150, according to Paul Brown, president of Roche Diagnostics.

Side effects from Zelboraf include rash, slight hair loss, extreme photosensitivity and joint pain. Roche filed for U.S. approval of the drug in April and the FDA had to make a decision by Oct. 28. Reuters reported on Aug. 10 that an early nod was likely.

http://www.cnbc.com/id/44178560?__source=RSS*tag*&par=RSS

 

More Read

Medical Imaging March Madness – Stage 2 and the Health Affairs IT Study Debate
Paying Bills: A Novel Idea in Southern Europe
Scrutinizing Adherence Must Not Be Shortsighted
Hospital Infection Rates Decreasing
The Importance of Clear Communications in Clinical Trial Marketing

TAGGED:FDAhealthcare businessRoche Pharmaceuticalsskin cancerZelboraf
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Free market for surgery: interview with Allevion CEO Arnon Krongrad, MD

January 7, 2016

Patient Recovery: It Takes a Village

January 22, 2014
hospital front desk
Hospital Administration

How does NHS procurement operate?

June 24, 2021
Hospital Administration

Was Granny Sent Home from the Hospital Too Soon?

December 14, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?